COLOGNE (Dow Jones) – Asset Management GmbH (UEM) the industrialist family Merckle is after the sale of Ulm Generic manufacturer ratiopharm debt free. The buyer, the Israeli Generics manufacturer Teva acquired for EUR 3.625 billion Ulm’s competitors, such as the Accompanying trustee sale, Hans-Joachim Ziems am Said Thursday in Cologne.
A sale or partial sale of the pharmaceutical wholesaler Phoenix, who is also the holding company for the beginning of 2009, the late businessman Adolf Merckle heard, it seems, at least for now off the table be. Recent Dow Jones Newswires had been familiar with the matter of People learn that a partial sale of Phoenix to debt relief for the VEM likely to be provided ratiopharm sells for only around 3 billion EUR would. Now made the sale of ratiopharm described Meanwhile Ziems as necessary to reduce the debt burden of the UEM.
DJG / eyh / jhe Visit our website http://www.dowjones.de
(END) Dow Jones Newswires
March 18, 2010 09:32 ET (13:32 GMT)
Copyright (c) 2010 Dow Jones & Company, Inc.